Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Sporadic trichoblastic neoplasms generally don't recur or spread, with one case showing a specific genetic fusion.

Certain genetic variations are linked to higher liver enzyme levels in patients treated for chronic hepatitis C with specific drugs.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Finasteride improves prostate cancer prediction by adjusting kallikrein marker levels.

Finasteride therapy reduces PSA levels and prostate size, helping diagnose prostate cancer.

Finasteride and dutasteride reduce prostate cancer risk, but finasteride may increase higher-grade cancer risk.

Extending androgen suppression before radiotherapy offers no extra survival benefit for intermediate-risk prostate cancer.

Dutasteride can reduce night-time urination but it doesn't improve sleep quality.

Finasteride and dutasteride both increase chromogranin A levels similarly.

Endurance exercise may help BPH by lowering hormones and inflammation.

5ARIs lower PSA levels, but other tests are needed to avoid missing aggressive prostate cancer.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.

The meeting highlighted promising genetic treatments for male fertility issues but noted concerns about certain cancer risks and ICSI safety.

Castration significantly reduces prostate size and BPH symptoms.

Targeting ACE2 and TMPRSS2 may help prevent or treat COVID-19 in cancer patients.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Prostate cancer prevention now focuses on healthy diets and some medications, not vitamins.

Testosterone with finasteride improved muscle and bone health in men with spinal cord injury.

Androgens, male hormones, affect physical and mental functions, with a decrease leading to health issues like muscle loss, bone disease, and depression, and more research is needed on long-term effects and treatments.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Higher testosterone levels can increase the risk of certain diseases like type 2 diabetes in women and prostate cancer in men, but can also protect against autoimmune diseases and hair loss. It also affects body fat and bone density.

Long-term high testosterone levels can improve bone density and reduce body fat but may increase the risk of prostate cancer and high blood pressure.

Lack of sleep in mice leads to prostatitis by reducing certain hormones and activating an inflammatory pathway, which can be temporarily fixed with normal sleep.

Increased free testosterone can lead to stronger bones and less body fat but also higher risks of prostate cancer, hair loss, spine issues, and high blood pressure.